Intragenic anaplastic lymphoma kinase (ALK) rearrangements: Translocations as a novel mechanism ofALKactivation in neuroblastoma tumors-Reference-Cited by-同舟云学术

Intragenic anaplastic lymphoma kinase (ALK) rearrangements: Translocations as a novel mechanism ofALKactivation in neuroblastoma tumors

Published:2014-09-23 Issue:2 Volume:54 Page:99-109
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Fransson Susanne¹,Hansson Magnus²³,Ruuth Kristina⁴,Djos Anna¹,Berbegall Ana⁵,Javanmardi Niloufar¹,Abrahamsson Jonas⁶,Palmer Ruth H.⁴⁷,Noguera Rosa⁵,Hallberg Bengt⁴⁷,Kogner Per⁸,Martinsson Tommy¹

Affiliation:

1. Department of Medical and Clinical Genetics; Sahlgrenska Academy at the University of Gothenburg; Gothenburg Sweden

2. Department of Pathology; Sahlgrenska Academy at University of Gothenburg; Gothenburg Sweden

3. Department of Medical Biosciences, Section for Pathology; Umeå University; Umeå Sweden

4. Department of Molecular Biology; Umeå University; Umeå Sweden

5. Department of Pathology, Medical School; University of Valencia, INCLIVA; Valencia Spain

6. Department of Pediatrics; Sahlgrenska Academy at University of Gothenburg; Gothenburg Sweden

7. Department of Medical Chemistry and Cell Biology; Sahlgrenska Academy at the University of Gothenburg; Gothenburg Sweden

8. Department of Women's and Children's Health; Childhood Cancer Research Unit; Karolinska Institutet; Stockholm Sweden

Funder

BioCARE - a National Strategic Research Program

FIS and RTICC, Instituto Carlos III Madrid and European Regional Development Fund

Sahlgrenska University Hospital Laboratory Medicine Grants

the Assar Gabrielsson Foundation

The ChildrenÂ´s Cancer Foundation

the Selma Andersson foundation

The Swedish Cancer Society

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gcc.22223/fullpdf

Reference30 articles.

1. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor;Butrynski;N Engl J Med,2010

2. Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment;Camidge;Clin Cancer Res,2010

3. High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours;Caren;Biochem J,2008

4. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset;Caren;Proc Natl Acad Sci USA,2010

5. Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma;Cazes;Cancer Res,2013

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Antitumor Effects of 177Lu-Octreotide Combined with an ALK Inhibitor in a High-Risk Neuroblastoma Xenograft Model;Therapeutics;2024-08-07

2. mRNA Expression Level of ALK in Neuroblastoma Is Associated with Histological Subtype, ALK Mutations and ALK Immunohistochemical Protein Expression;Journal of Molecular Pathology;2024-08-01

3. Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice;Heliyon;2024-05

4. Genomic ALK alterations in primary and relapsed neuroblastoma;British Journal of Cancer;2023-02-17

5. The ubiquitin-ligase TRAF6 and TGFβ type I receptor form a complex with Aurora kinase B contributing to mitotic progression and cytokinesis in cancer cells;eBioMedicine;2022-08